Ticker
ACST

Price
0.89
Stock movement down
-0.00 (-0.37%)
Company name
Acasti Pharma Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
39.49M
Ent value
29.50M
Price/Sales
308.51
Price/Book
0.36
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-76.37%
3 year return
-60.34%
5 year return
-39.05%
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ACST does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales308.51
Price to Book0.36
EV to Sales230.47

FINANCIALS

Per share

Loading...
Per share data
Current share count44.44M
EPS (TTM)-0.66
FCF per share (TTM)-1.16

Income statement

Loading...
Income statement data
Revenue (TTM)128.00K
Gross profit (TTM)75.00K
Operating income (TTM)-15.59M
Net income (TTM)-9.82M
EPS (TTM)-0.66
EPS (1y forward)-0.55

Margins

Loading...
Margins data
Gross margin (TTM)58.59%
Operating margin (TTM)-12178.91%
Profit margin (TTM)-7671.09%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash30.34M
Net receivables548.00K
Total current assets45.53M
Goodwill12.96M
Intangible assets69.81M
Property, plant and equipment0.00
Total assets128.62M
Accounts payable1.68M
Short/Current long term debt295.00K
Total current liabilities3.26M
Total liabilities20.35M
Shareholder's equity108.27M
Net tangible assets25.50M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-17.23M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-17.23M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-9.07%
Return on Assets-7.63%
Return on Invested Capital-9.06%
Cash Return on Invested Capital-15.90%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.89
Daily high0.89
Daily low0.88
Daily Volume60K
All-time high325.60
1y analyst estimate5.04
Beta1.43
EPS (TTM)-0.66
Dividend per share-
Ex-div date-
Next earnings date8 Nov 2022

Downside potential

Loading...
Downside potential data
ACSTS&P500
Current price drop from All-time high-99.73%-12.18%
Highest price drop-99.75%-56.47%
Date of highest drop1 Aug 20229 Mar 2009
Avg drop from high-84.28%-11.38%
Avg time to new high72 days12 days
Max time to new high2272 days1805 days
COMPANY DETAILS
ACST (Acasti Pharma Inc) company logo
Marketcap
39.49M
Marketcap category
Small-cap
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Employees
0
Investor relations
-
SEC filings
CEO
Janelle D'Alvise
Country
USA
City
Laval
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Phoenix, Arizona--(Newsfile Corp. - September 21, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"), a specialty pharma company with drug delivery technologies a...
September 21, 2022
LAVAL, Québec, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capability an...
September 14, 2022
LAVAL, Québec, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces the initiation of its planned pharmacokinetic (PK) brid...
September 13, 2022
LAVAL, Québec, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capability an...
September 12, 2022
Company to Host Conference Call Today at 1:00pm ETLAVAL, Québec, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialt...
August 11, 2022
Call to be held on Thursday, August 11th at 1:00 PM Eastern Time LAVAL, Quebec, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), today a...
August 2, 2022
LAVAL, Quebec, July 27, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces the initiation of its planned pharmacokinetic (PK) bridg...
July 27, 2022
Phoenix, Arizona--(Newsfile Corp. - July 7, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"), a specialty pharma company with drug delivery technologies and nov...
July 7, 2022
LAVAL, Québec, June 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company with drug delivery capability and...
June 22, 2022
Next page